Management of precision diagnostics and personalized treatment of reproductive disorders
Reproductive system diseases are a major public health concern, affecting a significant portion of both males and females globally. Personalized medicine has emerged as a crucial tool in addressing this growing epidemiology by utilizing state-of-the-art molecular technologies, such as genomic sequencing, proteomics, and transcriptomics, to gather specific information about an individual’s genetics, molecular makeup, and disease state. This information is used to create personalized treatment plans tailored to each patient’s specific needs and biology, offering the potential to improve the accuracy of diagnoses, increase treatment efficacy, and reduce adverse drug reactions. For males, reproductive system diseases can include infertility, erectile dysfunction, and testicular cancer. For females, these diseases may include infertility, menstrual disorders, polycystic ovary syndrome (PCOS), and cervical cancer
